IR InformationFY2023 Third Quarter Financial Results Presentation Summary of Q&A Session
IR InformationAnnouncement of Discontinuation of Development of a Norovirus Vaccine in an Overseas Consolidated Subsidiary and Recording of Extraordinary Loss
IR InformationFY2023 Third Quarter Financial Results Presentation Materials
IR InformationNotice Regarding Changes in Executive Officers
IR InformationFY2023 Third Quarter Summary of Consolidated Financial Statements
NewsDonations to Individuals and Areas Affected by the 2024 Noto Peninsula Earthquake
NewsImpact of the 2024 Noto Peninsula Earthquake
NewsInvestment in Start-up for the Commercialization of Wearable Biosensor Measuring Health Data Using Sweat - The first investment via Denka’s new CVC fund -
NewsNew Year’s Message
This website uses cookies to ensure that you use this website comfortably. If you continue to browse this website, you will agree to the use of our cookies.